Your browser doesn't support javascript.
loading
Assessment of Cardiovascular Safety of Anti-Osteoporosis Drugs.
Fuggle, N R; Cooper, C; Harvey, N C; Al-Daghri, N; Brandi, M-L; Bruyere, O; Cano, A; Dennison, E M; Diez-Perez, A; Kaufman, J-M; Palacios, S; Prieto-Alhambra, D; Rozenberg, S; Thomas, T; Tremollieres, F; Rizzoli, R; Kanis, J A; Reginster, J Y.
Afiliação
  • Fuggle NR; MRC Lifecourse Epidemiology Unit, University of Southampton, Tremona Road, Southampton, SO16 6YD, UK.
  • Cooper C; MRC Lifecourse Epidemiology Unit, University of Southampton, Tremona Road, Southampton, SO16 6YD, UK. cc@mrc.soton.ac.uk.
  • Harvey NC; NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, UK. cc@mrc.soton.ac.uk.
  • Al-Daghri N; MRC Lifecourse Epidemiology Unit, University of Southampton, Tremona Road, Southampton, SO16 6YD, UK.
  • Brandi ML; Chair for Biomarkers of Chronic Diseases, Biochemistry Department, College of Science, King Saud University, Riyadh, Kingdom of Saudi Arabia.
  • Bruyere O; Unit of Bone and Mineral Diseases, Department of Surgery and Translational Medicine, University Hospital of Florence, University of Florence, 50139, Florence, Italy.
  • Cano A; WHO Collaborating Centre for Public Health Aspects of Musculoskeletal Health and Aging, Liège, Belgium.
  • Dennison EM; Department of Obstetrics and Gynecology, University of Valencia and INCLIVA Health Research Institute, Valencia, Spain.
  • Diez-Perez A; MRC Lifecourse Epidemiology Unit, University of Southampton, Tremona Road, Southampton, SO16 6YD, UK.
  • Kaufman JM; Hospital del Mar Research Institute (IMIM), Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Barcelona, Spain.
  • Palacios S; Internal Medicine Department, Hospital del Mar, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Prieto-Alhambra D; Department of Endocrinology, Ghent University Hospital, 9000, Ghent, Belgium.
  • Rozenberg S; The Palacios Institute of Women's Health, Madrid, Spain.
  • Thomas T; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK.
  • Tremollieres F; Department of Obstetrics and Gynecology, CHU St Pierre, Laboratoire de Santé Génésique Université Libre de Bruxelles, Brussels, Belgium.
  • Rizzoli R; Department of Rheumatology, Hôpital Nord, CHU de Saint-Etienne, and INSERM U1059, Université de Lyon, Saint-Etienne, France.
  • Kanis JA; Menopause Centre, Hôpital Paule de Viguier, University Hospital of Toulouse and INSERM U1048-I2MC, Equipe 9, Toulouse, France.
  • Reginster JY; Service of Bone Diseases, Geneva University Hospitals and Faculty of Medicine, 1211, Geneva 14, Switzerland.
Drugs ; 80(15): 1537-1552, 2020 Oct.
Article em En | MEDLINE | ID: mdl-32725307
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteoporose / Acidente Vascular Cerebral / Conservadores da Densidade Óssea / Tromboembolia Venosa / Placa Aterosclerótica Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Drugs Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Nova Zelândia
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteoporose / Acidente Vascular Cerebral / Conservadores da Densidade Óssea / Tromboembolia Venosa / Placa Aterosclerótica Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Drugs Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Nova Zelândia